Afya Leads a Brazilian Education Selloff, But Shorts Have Already Retreated

AFYA has dropped 31% in a single week to $10.45, yet the most striking detail is that short sellers appear to have already taken profits on the move, leaving the stock's next chapter less about positioning pressure and more about what the November earnings print reveals.

The selloff has hit Brazilian education broadly. Peers ANIM3 and COGN3 fell 55% and 49% respectively on the week, while YDUQ3 dropped 37%. AFYA at minus 31% actually held up better than most. HRB on the NYSE was the outlier, gaining 3%, a reminder that the damage is concentrated in Brazilian-listed education names. Whatever catalyst drove the sector lower, it appears systemic rather than company-specific.

Short positioning tells an unusual story for a stock in freefall. Short interest in AFYA plunged 77% over the past week, from around 1.9 million shares to just under 440,000, collapsing from roughly 4% of the free float to below 1%. That is a dramatic unwind. The borrow market, however, is moving the opposite way. Cost to borrow more than doubled on the week to 6.2%, a level that is itself more than three times higher than a month ago. Availability is currently at 316%, meaning there is ample stock available to borrow relative to what is actually shorted, so the cost spike is not a supply squeeze. It looks instead like the price of hedging a stock that just moved 30% in a week. The ORTEX short score has also fallen sharply, dropping from around 68 last week to 44 today, consistent with a stock where the bearish thesis has partially played out and shorts have covered.

Options traders have turned more defensive than usual in response to the drop. The put/call ratio has climbed to 0.99, nearly 1.8 standard deviations above its 20-day average of 0.53. That is a meaningful shift: for most of October the ratio sat below 0.56, and the jump to near parity happened almost entirely this week. With earnings due on November 12, about two weeks out, some of the put demand likely reflects investors buying protection ahead of the print rather than outright bearish conviction.

The analyst picture is constructive on paper but the numbers deserve scrutiny. JP Morgan upgraded AFYA to Overweight on October 7, even as Marcelo Santos cut the target from $21 to $19, placing the stock well above current levels at $10.45. The consensus sits at hold from two buys and three holds, but every firm that has acted in 2026 has been cutting targets. Morgan Stanley moved to Underweight in February with a $16 target. B of A downgraded to Neutral the same month with a $17 target. The mean price target of $87 in the data looks inconsistent with these recent actions and the current price, and should be treated with caution; the individual targets cited above, ranging from $16 to $19, are more reliable anchors. Factor scores add a further complication: the stock ranks in the 96th percentile for EPS surprise and the 92nd for EV/EBIT value, but momentum scores sit in the 14th percentile over 30 days, a valuation story that has not yet found a price floor.

Ownership concentration is notable. Bertelsmann holds a 13D activist stake at 72.3% of the class, trimmed from 75.3% at the prior filing, and the combined institutional picture leaves very little float in active hands. Bertelsmann's continued trimming, even modestly, is worth watching. The Doma Perpetual Capital and FMR positions both increased into mid-year, which at least suggests some institutional interest at prices above where the stock now trades.

Wikipedia attention for AFYA has spiked to a z-score of 10, the ceiling of the measure, as of October 25, reflecting the sharp rise in retail attention that tends to accompany a move of this magnitude. That is a gauge of attention, not a revenue indicator.

The next meaningful data point is the November 12 earnings report. At the last print on October 20, the stock barely moved on the day but fell 28% over the following five days, which may explain some of the put demand building now. Whether the Street uses the earnings call to reset expectations or to start rebuilding into a stock that screens cheap on earnings yield and EV/EBITDA is the question the next twelve days will answer.